Page last updated: 2024-10-24

negative regulation of secretion of lysosomal enzymes

Definition

Target type: biologicalprocess

Any process that decreases the rate, frequency or extent of secretion of lysosomal enzymes, the controlled release of lysosomal enzymes by a cell. [GOC:BHF]

Negative regulation of secretion of lysosomal enzymes is a complex process that involves a coordinated interplay of various cellular mechanisms. Lysosomal enzymes, which are essential for intracellular degradation and recycling, are synthesized in the endoplasmic reticulum (ER) and subsequently transported through the Golgi apparatus to lysosomes. However, the release of these enzymes into the extracellular space can be detrimental, leading to cellular damage and inflammation. Therefore, cells have evolved intricate regulatory pathways to tightly control the secretion of lysosomal enzymes.

One crucial mechanism involves the regulation of lysosomal enzyme trafficking through the secretory pathway. Lysosomes are acidic organelles that maintain a low pH, and this acidic environment is essential for the proper functioning of lysosomal enzymes. The pH of the lysosomal lumen is regulated by proton pumps, which pump protons into the lysosome, lowering its pH. Changes in the pH of the lysosome can affect the activity of lysosomal enzymes and their trafficking through the secretory pathway.

Another important aspect of negative regulation is the sorting of lysosomal enzymes. Specific sorting signals embedded in the lysosomal enzyme proteins guide their trafficking to lysosomes. These signals can be recognized by adaptor proteins that facilitate the packaging of lysosomal enzymes into transport vesicles. Mutations in these sorting signals or in the adaptor proteins can lead to the misdirection of lysosomal enzymes, resulting in their secretion instead of delivery to lysosomes.

In addition to the sorting and trafficking of lysosomal enzymes, the secretion of these enzymes can be regulated by various signaling pathways. For example, growth factors and other stimuli can trigger the activation of signaling cascades that lead to the phosphorylation of specific proteins involved in lysosomal enzyme trafficking. These phosphorylation events can alter the interactions between lysosomal enzymes and their transport machinery, ultimately affecting the efficiency of lysosomal enzyme secretion.

Furthermore, the secretion of lysosomal enzymes can be modulated by the cellular environment. Cells can respond to stress conditions, such as hypoxia or nutrient deprivation, by altering the secretion of lysosomal enzymes. For example, under conditions of nutrient deprivation, cells may increase the secretion of lysosomal enzymes to break down extracellular components and provide a source of nutrients.

In conclusion, negative regulation of secretion of lysosomal enzymes involves a multifaceted process that ensures the proper delivery and retention of these enzymes within lysosomes. This tight control is essential for maintaining cellular homeostasis and preventing the detrimental effects of lysosomal enzyme leakage into the extracellular space.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Oxysterols receptor LXR-alphaAn oxysterols receptor LXR-alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q13133]Homo sapiens (human)

Compounds (30)

CompoundDefinitionClassesRoles
1-deoxynojirimycin1-deoxy-nojirimycin: structure in first source

duvoglustat : An optically active form of 2-(hydroxymethyl)piperidine-3,4,5-triol having 2R,3R,4R,5S-configuration.
2-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid
anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite
betulinic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
25-hydroxycholesterol25-hydroxy steroid;
oxysterol
human metabolite
bexarotenebenzoic acids;
naphthalenes;
retinoid
antineoplastic agent
3 beta-hydroxy-delta 5-cholenic acidsteroid
podocarpic acidpodocarpic acid : An abietane diterpenoid lacking the isopropyl substituent with an aromatic C-ring and a hydroxy group at the 12-position.

podocarpic acid: structure
abietane diterpenoid
(20s)-20-hydroxycholesterol20-hydroxycholesterol : An oxysterol that is cholesterol substituted by a hydroxy group at position 20.

20-hydroxycholesterol: RN given refers to (20S)-isomer
20-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
oxysterol
human metabolite;
mouse metabolite
24-hydroxycholesterol(24S)-24-hydroxycholesterol : A 24-hydroxycholesterol that has S configuration at position 24. It is the major metabolic breakdown product of cholesterol in the brain.24-hydroxycholesterolbiomarker;
human blood serum metabolite;
mouse metabolite
27-hydroxycholesterol(25R)-cholest-5-ene-3beta,26-diol : A 26-hydroxycholesterol in which the 25-position has R-configuration.26-hydroxycholesterolapoptosis inducer;
human metabolite;
mouse metabolite;
neuroprotective agent
cyanidincyanidin cation : An anthocyanidin cation that is flavylium substituted at positions 3, 3', 4', 5 and 7 by hydroxy groups.

cyanidin: RN given refers to parent cpd; structure
5-hydroxyanthocyanidinantioxidant;
metabolite;
neuroprotective agent
(22r)-22-hydroxycholesterol(22R)-22-hydroxycholesterol : An oxysterol that is the 22R-hydroxy derivative of cholesterol.22-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
oxysterol
22s-hydroxycholesterol(22S)-22-hydroxycholesterol : An oxysterol that is the 22S-hydroxy derivative of cholesterol.22-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
oxysterol
gw 3965GW 3965: a liver X receptor liganddiarylmethane
t0901317T0901317: an LXRalpha and LXRbeta agonist
alitretinoinAlitretinoin: A retinoid that is used for the treatment of chronic hand ECZEMA unresponsive to topical CORTICOSTEROIDS. It is also used to treat cutaneous lesions associated with AIDS-related KAPOSI SARCOMA.retinoic acidantineoplastic agent;
keratolytic drug;
metabolite;
retinoid X receptor agonist
24,25-epoxycholesterol24,25-epoxycholesterol: Rn given refers to (3alpha,5beta)-isomer; structure given in first source

24(S),25-epoxycholesterol : A 3beta-hydroxy-Delta(5)-steroid that is desmosterol in which the double bond at position 24-25 has been oxidised to the corresponding epoxide (the 24S diastereoisomer). It is an oxysterol agonist of the liver X receptor.
3beta-hydroxy-Delta(5)-steroid;
cholestanoid;
epoxy steroid
liver X receptor agonist
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
piericidin apiericidin A : A member of the class of monohydroxypyridines that acts as an irreversible mitochondrial Complex I inhibitor that strongly associates with ubiquinone binding sites in both mitochondrial and bacterial forms of NADH:ubiquinone oxidoreductase

piericidin A: pyridine-substituted fatty alcohol antibiotic; minor descriptor (75-85); on-line & Index Medicus search ANTIBIOTICS (75-85); RN given refers to (S-(R*,R*-(all-E)))-isomer
aromatic ether;
methylpyridines;
monohydroxypyridine;
secondary allylic alcohol
antimicrobial agent;
bacterial metabolite;
EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor;
mitochondrial respiratory-chain inhibitor
pregna-4,17-diene-3,16-dionepregna-4,17-diene-3,16-dione: steroid from guggulu extract; RN & N1 from C1 Form index; RN given refers to cpd without isomeric designation; structure in first source; antagonist of farnesoid X receptor3-hydroxy steroidandrogen
acanthoic acidacanthoic acid: from root bark of Acanthopanax koreanum; structure given in first source
3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acid
riccardin criccardin C: isolated from liverworts; functions as a liver X receptor (LXR)alpha agonist and an LXRbeta antagonist; structure in first source
bms 687453
way 2526232-(2-chloro-4-fluorobenzyl)-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole: a partial LXR agonist
cholenic acid dimethylamidecholenic acid dimethylamide: binds LXRalpha receptor; structure in first source
glucopiericidin aglucopiericidin A: from Streptomyces pactum S48727 as co-metabolite of piericidin A(1); structure given in first source; glycoside antibiotic
gsk4112GSK4112: a Rev-erbalpha agonist; structure in first source
sr9009
sr9011SR9011: a REV-ERB agonist; structure in first source
sr9238SR9238: liver-selective LXR inverse agonist that suppresses hepatic steatosis; structure in first source